Plasma ceramides relate to mild cognitive impairment in middle‐aged men: The Maastricht Study

INTRODUCTION: There is an urgent need for biomarkers identifying individuals at risk of early‐stage cognitive impairment. Using cross‐sectional data from The Maastricht Study, this study included 197 individuals with mild cognitive impairment (MCI) and 200 cognitively unimpaired individuals aged 40...

Descripción completa

Detalles Bibliográficos
Autores principales: van Kruining, Daan, Losen, Mario, Crivelli, Simone M., de Jong, Joost J. A., Jansen, Jacobus F. A., Backes, Walter H., Monereo‐Sánchez, Jennifer, van Boxtel, Martin P. J., Köhler, Sebastian, Linden, David E. J., Schram, Miranda T., Mielke, Michelle M., Martinez‐Martinez, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478166/
https://www.ncbi.nlm.nih.gov/pubmed/37675435
http://dx.doi.org/10.1002/dad2.12459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478166/
https://www.ncbi.nlm.nih.gov/pubmed/37675435
http://dx.doi.org/10.1002/dad2.12459

Ejemplares similares